Cisplatin

colony stimulating factor 3 ; Homo sapiens







65 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
51 8749950 Shorter interval between cycles of cyclophosphamide, doxorubicin, cisplatin using recombinant human granulocyte colony-stimulating factor for urothelial cancer--phase I/II study. 1995 Nov 1
52 7512280 Effect of recombinant human granulocyte colony-stimulating factor in patients receiving methotrexate/vinblastine/doxorubicin/cisplatin therapy for the treatment of transitional cell carcinoma of the urinary tract. 1994 Feb 1
53 7512356 A study of dose escalation of teniposide (VM-26) plus cisplatin (CDDP) with recombinant human granulocyte colony-stimulating factor (rhG-CSF) in patients with advanced small cell lung cancer. 1994 1
54 7513844 Clinical efficacy of recombinant human granulocyte colony-stimulating factor in patients with head and neck cancer. 1994 Mar-Apr 1
55 7521906 Doxorubicin and cisplatin with granulocyte colony-stimulating factor as adjuvant chemotherapy for osteosarcoma: phase II trial of the European Osteosarcoma Intergroup. 1994 Sep 2
56 7525886 Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer. 1994 Nov 1
57 7527732 M-VEC (methotrexate, vinblastine, epirubicin, and cisplatin) with granulocyte colony-stimulating factor for the treatment of urothelial cancer: an effective and safe chemotherapy regimen. 1994 1
58 7907208 Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies. 1994 Mar 1
59 7685138 [Effect of recombinant human granulocyte colony stimulating factor in patients with transitional cell carcinoma of the urothelium receiving methotrexate, etoposide and cisplatinum combination chemotherapy]. 1993 Mar 2
60 7692001 Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting. 1993 Oct 3
61 7692928 Peripheral blood progenitor cells mobilized by chemotherapy plus granulocyte-colony stimulating factor accelerate both neutrophil and platelet recovery after high-dose VP16, ifosfamide and cisplatin. 1993 Jul 1
62 8385969 Recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for non-small cell lung cancer. 1993 1
63 1281446 The use of granulocyte colony-stimulating factor to shorten the interval between cycles of mitomycin C, vindesine, and cisplatin chemotherapy in non-small-cell lung cancer. 1992 1
64 1381342 Granulocyte-colony-stimulating factor enhances the circulating hematopoietic progenitors in lung cancer patients treated with cisplatin-containing regimens. 1992 Jul 1
65 1384952 Acute arterial thrombosis after escalated-dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy with recombinant granulocyte colony-stimulating factor. A possible new recombinant granulocyte colony-stimulating factor toxicity. 1992 Dec 1 1